Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure
2008 · New England Journal of Medicine · 1,562 citations
https://doi.org/10.1056/nejmoa0708789
M
Mario Talajic
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
450
Papers
32.4K
Citations
85
h-index
235
i10-index
Mario Talajic is an academic researcher from Montreal Heart Institute. The author has contributed to research in topics: Cardiac Arrhythmias and Treatments & Atrial Fibrillation Management and Outcomes & Cardiac electrophysiology and arrhythmias. The author has an h-index of 85, co-authored 383 publications.
ORCID: 0000-0001-8469-4748Papers by this author
worksShared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
2021 · Nature Genetics · 285 citations
https://doi.org/10.1038/s41588-020-00762-2
<i> <scp>TECRL</scp> </i> , a new life‐threatening inherited arrhythmia gene associated with overlapping clinical features of both <scp>LQTS</scp> and <scp>CPVT</scp>
2016 · EMBO Molecular Medicine · 129 citations
https://doi.org/10.15252/emmm.201505719
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy
2025 · Nature Genetics · 43 citations
https://doi.org/10.1038/s41588-025-02087-4
An Open-Label Study of Nefazodone Treatment of Major Depression in Patients with Congestive Heart Failure
2003 · The Canadian Journal of Psychiatry · 37 citations
https://doi.org/10.1177/070674370304801009
Cryoballoon Ablation for Atrial Fibrillation
2012 · Indian Pacing and Electrophysiology Journal · 33 citations
https://doi.org/10.1016/s0972-6292(16)30479-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat